LadRx Corporation (LADX)
OTCMKTS
· Delayed Price · Currency is USD
0.1100
-0.0900 (-45.00%)
At close: Dec 5, 2025
LadRx Employees
LadRx had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,247,856
Market Cap
54.46K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
LadRx News
- 9 months ago - LadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13th - GlobeNewsWire
- 1 year ago - LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates - Business Wire
- 2 years ago - LadRx Issues 2024 Update to Shareholders - Business Wire